drugset / Trial / NCT00358488

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

NCT00358488

Phase 2 Completed 54 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study is designed to determine the efficacy and safety of a new long-acting beta-agonist for asthma patients (GSK159797) following dosing for 14 days.

Timeline

Start
2006-04
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject MILVETEROL Small molecule 10 ug Inhaled
Subject MILVETEROL Small molecule 15 ug Inhaled
Subject MILVETEROL Small molecule 20 ug Inhaled
Subject Salbutamol Unknown
Subject Salmeterol Other / unclassified 50 ug